Zoledronic acid increases bone mineral density in patients with thalassemia intermedia-induced osteoporosis despite the continuous bone marrow expansion

被引:0
|
作者
Voskaridou, E.
Christoulas, D.
Antoniadou, L.
Tsaftaridis, P.
Plata, E.
Terpos, E.
机构
[1] Laikon Gen Hosp, Thalassemia Ctr, Athens, Greece
[2] Gen Air Force Hosp 254, Athens, Greece
[3] Bioiatriki Med Ctr, Athens, Greece
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0914
引用
收藏
页码:342 / 342
页数:1
相关论文
共 50 条
  • [41] Profound effect of zoledronic acid on bone mineral density in rheumatoid arthritis
    Jarrett, S
    Conaghan, P
    Papanastasiou, P
    Sloan, V
    Rees-Evans, B
    Stewart, S
    Mesenbrink, P
    Richardson, P
    Emery, R
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 264 - 264
  • [42] Bone mineral density in patients with inherited bone marrow failure syndromes
    Shankar, Roopa Kanakatti
    Giri, Neelam
    Lodish, Maya B.
    Sinaii, Ninet
    Reynolds, James C.
    Savage, Sharon A.
    Stratakis, Constantine A.
    Alter, Blanche P.
    PEDIATRIC RESEARCH, 2017, 82 (03) : 458 - 464
  • [43] Bone mineral density in patients with inherited bone marrow failure syndromes
    Roopa Kanakatti Shankar
    Neelam Giri
    Maya B Lodish
    Ninet Sinaii
    James C Reynolds
    Sharon A Savage
    Constantine A Stratakis
    Blanche P Alter
    Pediatric Research, 2017, 82 : 458 - 464
  • [44] THE EFFECT OF INTRAVENOUS ZOLEDRONIC ACID ON BONE MINERAL DENSITY IN AN ELDERLY POPULATION
    Naureen, Mahwish
    Ahmed, Syed Roman
    Siddique, Najia
    McCarroll, Kevin
    Casey, Miriam
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S307 - S307
  • [45] Octreotide increases bone mineral density in a patient with carcinoid and osteoporosis.
    McCommon, D
    Tauer, K
    Palmieri, GM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S380 - S380
  • [46] Alendronate increases bone mineral density in male idiopathic osteoporosis.
    Weber, TJ
    Drezner, MK
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S278 - S278
  • [47] Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer
    Ryan, Christopher W.
    Huo, Dezheng
    Demers, Laurence M.
    Beer, Tomasz M.
    Lacerna, Leo V.
    JOURNAL OF UROLOGY, 2006, 176 (03): : 972 - 978
  • [48] The Relationship Between Iron Accumulation, Vitamin D Deficiency and Bone Mineral Density in Patients with Thalassemia Major, Thalassemia Intermedia and Sickle Cell
    Buyuksimsek, Mahmut
    Baslamisli, Ismail Fikri
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2020, 26 (02): : 121 - 126
  • [49] The effect of simvastatin on bone mineral density and bone turnover of diabetic osteoporosis patients
    白洁
    王洪庆
    陈凌
    中国临床康复, 2003, (05) : 870 - 873
  • [50] High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
    Voskaridou, E.
    Christoulas, D.
    Plata, E.
    Bratengeier, C.
    Anastasilakis, A. D.
    Komninaka, V.
    Kaliontzi, D.
    Gkotzamanidou, M.
    Polyzos, S. A.
    Dimopoulou, M.
    Terpos, E.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (12) : 909 - 913